
AcquisitionCommerce & Consumer Brands
Honasa acquires 58% stake in Fluence Pharma
By Abha Lohia · Editor ·
Honasa Consumer: revenue and funding and every story →
Founded 2016
- Honasa Consumer owns brands like Mamaearth and The Derma Co
- It bought a 58% stake in Fluence Pharma for ₹135 Cr via secondary purchase
- The deal helps Honasa enter the nutraceuticals market, valued at ₹16,000 Cr in India
What happened
- Honasa Consumer's board approved the acquisition of a 58% stake in Fluence Pharma for ₹135 Cr.
- The stake is bought via a secondary purchase from existing shareholders.
- The transaction is expected to close within eight weeks.
- Honasa will acquire the remaining 42% stake in two tranches over 5-7 years after the first phase.
- Honasa's board also approved setting up a wholly-owned subsidiary called Honasa Health.
- Honasa Health will build a nutraceuticals vertical with an initial paid-up capital of ₹1 lakh.
- Honasa Health will combine Fluence Pharma's Cyclical Nutrition Therapy (CNT) platform with Honasa's distribution and marketing.
Why it matters
- The acquisition aligns with Honasa's 3.0 strategy to double FY31 revenue to over ₹5,500 Cr and improve EBITDA margins above 15%.
- Honasa sees nutraceuticals as the next phase of growth in beauty and personal care, with consumers seeking inside-out solutions.
- India's nutraceuticals market is estimated at around ₹16,000 Cr.
- Large competitors like L'Oréal, HUL, Marico, and ITC have also acquired nutraceutical or beauty brands recently.
The business
- Honasa Consumer is a digital-first house of brands in beauty and personal care.
- It owns 8 brands including Mamaearth, The Derma Co., Aqualogica, Lumineve, Staze, BBlunt, Dr Sheth's, and Reginald Men.
- The company has an omni-channel presence across 750+ districts in India.
- Honasa plans to scale offline distribution from ~1.2 lakh outlets to over 3 lakh outlets.
- It projects Mamaearth revenue to exceed ₹2,000 Cr and The Derma Co. to cross ₹1,500 Cr by FY31.
- Honasa aims to build at least two additional brands with annual revenue over ₹500 Cr each.
- The company sees nutraceuticals, fragrances, and oral care as key next-horizon categories.
The founders
- Co-founded Honasa Consumer in 2016.
- No other background details provided in the facts.
- Co-founded Honasa Consumer in 2016.
- Serves as CEO of the company.
- Stated that nutraceuticals is the next phase of growth in beauty and personal care.
AB
Amit Bhusari
Co-founder of Fluence Pharma- Co-founded Fluence Pharma in 2012.
- No other background details provided in the facts.
DR
Dr Rajendra Singh Rajput
Co-founder of Fluence Pharma- Co-founded Fluence Pharma in 2012.
- No other background details provided in the facts.
In numbers
58%Stake acquired in Fluence Pharma · 2026
₹135 CrAcquisition amount · 2026
₹37.2 CrFluence Pharma FY25 turnover · 2025
₹40 CrFluence Pharma FY26 revenue · 2026
over 20%Fluence Pharma FY26 EBITDA margin · 2026
over 70%Revenue from hair-focused products · 2026
₹200.2 CrHonasa FY26 net profit · 2026
₹2,391.9 CrHonasa FY26 operating revenue · 2026
over ₹5,500 CrHonasa FY31 revenue target · 2031
₹16,000 CrIndia nutraceuticals market size · 2026
What happens next
- Honasa Health will be led by Dheeraj Nagpal, ex-co-founder of Zingavita.
- Honasa plans to scale offline distribution from ~1.2 lakh outlets to over 3 lakh outlets.
- The company aims to build at least two additional brands with annual revenue over ₹500 Cr each.
- Honasa will explore nutraceuticals, fragrances, and oral care as next-horizon categories.
Earlier rounds
- December 2025 · acquisition · Undisclosed · led by Honasa Consumer
Up against
L'OréalHULUSVMaricoITC
Words to know
- Secondary purchase
- Buying shares from existing shareholders rather than from the company itself; the money goes to the sellers, not the company.
- Nutraceuticals
- Products derived from food sources with extra health benefits, like dietary supplements and functional foods.
- Cyclical Nutrition Therapy (CNT)
- A patented platform by Fluence Pharma that uses a cycle-based approach to deliver nutrients for skin and hair health.
- EBITDA margin
- A measure of a company's operating profitability, calculated as earnings before interest, taxes, depreciation, and amortisation divided by revenue.
The numbers around it
Honasa Consumer has 1 funding rounds in StopDown's archive.
| When | Round | Amount | Led by |
|---|---|---|---|
| 5 January 2022 | Growth round | $52 M | Undefined |
Commerce & Consumer Brands in June 2026: 24 rounds with a disclosed amount, $298 million in all; the biggest was FirstClub ($55M). Every sector this year →
Other articles talking about it
Terms in this story
- Mergers and acquisitions: An acquisition is when one company buys another, and a merger is when two companies combine into one. For most Indian startups a sale is a likelier exit than an IPO, and the Competition Commission of India (CCI) must approve deals that cross its asset, turnover or ₹2,000 crore deal-value limits.
- Valuation: A private startup does not have a net worth you can look up. It has a valuation: a price tied to a funding round, a share sale or a company statement. Net worth means assets minus debts, and it belongs to people and listed companies. In Indian news, valued at usually points to a recent deal.
Read next
ResultsHonasa profit jumps 87% in second quarterHonasa Consumer is the Gurugram-based owner of the Mamaearth personal care brand and several other beauty labelsLaunchBlinkit starts ambulance service in BengaluruBlinkit is a quick-commerce app that delivers groceries and household items in minutes, and also runs an emergency ambulance servicePartnershipAtomberg and Voltas sign AC compressor ventureAtomberg makes energy-saving home appliances and has an Airtech subsidiary meant to build components for room air conditioners
Everything on Honasa Consumer → · All startup news on 23 June 2026 →
Is this Honasa Consumer? Get your “Featured on StopDown” badge →